Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 464814015 | Co-careldopa 12.5mg/50mg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 717333018 | Co-careldopa 12.5mg/50mg tablet (substance) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1190008018 | Co-careldopa 12.5mg/50mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2572057010 | Carbidopa+levodopa 12.5mg/50mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2576040013 | Carbidopa+levodopa 12.5mg/50mg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3483942014 | Product containing carbidopa 12.5 mg and levodopa 50 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3492494011 | Product containing carbidopa 12.5 mg and levodopa 50 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3500630013 | Carbidopa 12.5 mg and levodopa 50 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3566298014 | Product containing only carbidopa 12.5 mg and levodopa 50 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3566299018 | Product containing only carbidopa 12.5 mg and levodopa 50 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677288013 | Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677289017 | Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Is a | Co-careldopa | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has active ingredient | Carbidopa | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has active ingredient | Levodopa (substance) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Is a | Product containing carbidopa and levodopa (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Is a | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has active ingredient | Levodopa (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Levodopa (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 50 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has active ingredient | Carbidopa | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Carbidopa | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 12.5 | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Carbidopa | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 12.5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Levodopa (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 50 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has precise active ingredient | Carbidopa | false | Inferred relationship | Some | 1 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Has precise active ingredient | Levodopa (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet | Is a | Product containing only carbidopa and levodopa in oral dose form (medicinal product form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR